Join
Live feed
·
NEWSReleasevia Quantisnow
AstraZeneca PLC logo
Principal U.S. Large-Cap Multi-Factor Core Index ETF logo

AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer

ByQuantisnow·Wall Street's wire, on your screen.
AZN· AstraZeneca PLCPLC· Principal U.S. Large-Cap Multi-Factor Core Index ETF
Health Care